Sign inJoin waitlistJoin the waitlist

Roger Keresztes

Program Director, Hematology Oncology Fellowship Program · Stony Brook Medicine

Credentials: · ·

History

Hematology Oncology Fellowship · Stony Brook Medicine
Present
Stony Brook Medicine
Present

Hematology and Medical Oncology
New York Presbyterian Hospital
1990–1993
Internal Medicine
New York Presbyterian Hospital
1987–1990
Rutgers New Jersey Med Sch
1983–1987

Research

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
New England Journal of Medicine · 2003 · 922 citations
Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis
Systematic review or meta-analysis · JAMA · 2008 · 624 citations
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer
Journal of Clinical Oncology · 2003 · 230 citations

Nasser Altorki
7 papers
JP
Jeffrey Port
5 papers · 4 as a resident
Robert Korst
4 papers
TB
Thomas Brasitus
3 papers
MP
Mark Pasmantier
2 papers
Matthew Levin
2 papers
Shenhong Wu
2 papers
TB
Thomas Bilfinger
2 papers
Adam Khorasanchi
1 paper · 1 as a resident
Allyson Ocean
1 paper
Amna Sher
1 paper
AD
Andrew Dannenberg
1 paper

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $459 · Weill Medical Coll of Cornell Univ
2007

Clinical trials

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
Principal investigator · Terminated · Phase 1, Phase 2
Weill Medical College of Cornell University
2004–2006
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
Site PI · Unknown · Phase 2
CellSight Technologies, Inc.
2021–2024